Evaluation of an infographic: prescription drug misuse among older adults in Saskatchewan

References

• Abayateye, F., Fornssler, B., Feng, C., D’Arcy, C., & Alphonsus, K. (2022). Prescription drug misuse among adults in Canada: A scoping review. Journal of Substance Use, 28(3), 305–314. https://doi.org/10.1080/14659891.2022.2053890
   Web of Science ®Google Scholar
• Bulut, E. A., & Isik, A. T. (2022). Abuse/Misuse of prescription medications in older adults. Clinics in Geriatric Medicine, 38(1), 85–97. https://doi.org/10.1016/j.cger.2021.07.004
   PubMed Web of Science ®Google Scholar
• Canada Institute for Health Information. (2018). Drug use among seniors in Canada, 2016. https://secure.cihi.ca/free_products/drug-use-among-seniors-2016-en-web.pdf
   Google Scholar
• Canadian Centre on Substance Use and Addiction. (2022). Prescription drugs. https://www.ccsa.ca/prescription-drugs
   Google Scholar
• Canadian Harm Reduction Policy Project. (2017, August). Saskatchewan policy analysis case report.
   Google Scholar
• Carrière, G., Garner, R., & Sanmartin, C. (2021). Significant factors associated with problematic use of opioid pain relief medications among the household population, Canada, 2018. Health Reports, 32(12), 11–26. https://doi.org/10.25318/82-003-x202100700002-eng
   PubMed Web of Science ®Google Scholar
• Chang, Y.-P. (2018). Factors associated with prescription opioid misuse in adults aged 50 or older. Nursing Outlook, 66(2), 112–120. https://doi.org/10.1016/j.outlook.2017.10.007
   PubMed Web of Science ®Google Scholar
• Compton, W. M., & Volkow, N. D. (2006). Abuse of prescription drugs and the risk of addiction. Drug & Alcohol Dependence, 83(Suppl. 1), 4–7. https://doi.org/10.1016/j.drugalcdep.2005.10.020
   PubMed Web of Science ®Google Scholar
• Cuevas, C. D. L., Sanz, E. J., Fuente, J. A. D. L., Padilla, J., & Berenguer, J. C. (2000). The severity of dependence scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction, 95(2), 245–250. https://doi.org/10.1046/j.1360-0443.2000.95224511.x
   PubMed Web of Science ®Google Scholar
• Culberson, J. W., & Ziska, M. (2008). Prescription drug misuse/abuse in the elderly. Geriatrics, 63(9), 22–31.
   PubMed Web of Science ®Google Scholar
• de Lima, J. D., Teixeira, I. A., Silva, F. D. O., & Deslandes, A. C. (2020). The comorbidity conditions and polypharmacy in elderly patients with mental illness in a middle income country: A cross-sectional study. IBRO Reports, 9, 96–101. https://doi.org/10.1016/j.ibror.2020.07.008
   PubMedGoogle Scholar
• Dowse, R. (2004). Using visuals to communicate medicine information to patients with Low Literacy. Adult Learning, 15(1–2), 22–25. https://doi.org/10.1177/104515950401500106
   Google Scholar
• Feltenstein, M. W., & See, R. E. (2008). The neurocircuitry of addiction: An overview. British Journal of Pharmacology, 154(2), 261–274. https://doi.org/10.1038/bjp.2008.51
   PubMed Web of Science ®Google Scholar
• Furlan, A. D., MacDougall, P., Pellerin, D., Shaw, K., Spitzig, D., Wilson, G., & Wright, J. (2014). Overview of four prescription monitoring/review programs in Canada. Pain Research & Management, 19(2), 102–106. https://doi.org/10.1155/2014/634171
   PubMed Web of Science ®Google Scholar
• Grigsby, T. J., & Howard, J. T. (2019). Prescription opioid misuse and comorbid substance use: Past 30-day prevalence, correlates and co-occurring behavioral indicators in the 2016 national survey on drug use and health. The American Journal on Addictions, 28(2), 111–118. https://doi.org/10.1111/ajad.12866
   PubMed Web of Science ®Google Scholar
• Hogan, D. B., Maxwell, C. J., Fung, T. S., & Ebly, E. M. (2003). Prevalence and potential consequences of benzodiazepine use in senior citizens: Results from the Canadian study of health and aging. The Canadian Journal of Clinical Pharmacology = Journal Canadien de Pharmacologie Clinique, 10(2), 72–77.
   PubMedGoogle Scholar
• Holtfreter, K., Reisig, M. D., & O’neal, E. N. (2015). Prescription drug misuse in late adulthood: An empirical examination of competing explanations. Journal of Drug Issues, 45(4), 351–367. https://doi.org/10.1177/0022042615589405
   Web of Science ®Google Scholar
• Jörgensen, T., Johansson, S., Kennerfalk, A., Wallander, M. A., & Svärdsudd, K. K. (2001). Prescription drug use, diagnoses, and healthcare utilization among the elderly. The Annals of Pharmacotherapy, 35(9), 1004–1009. https://doi.org/10.1345/aph.10351
   PubMed Web of Science ®Google Scholar
• Jorgenson, D., Alazawi, D., Bareham, J., & Bootsman, N. (2021). Saskatchewan physicians’ opinions of their personalized prescribing profiles related to opioids, benzodiazepines, stimulants, and Gabapentin. Journal of Medical Regulation, 107(1), 7–16. https://doi.org/10.30770/2572-1852-107.1.7
   Google Scholar
• Kan, C. C., Breteler, M. H. M., Van der Ven, A. H. G. S., & Zitman, F. G. (2001). Cross-validation of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Comprehensive Psychiatry, 42(5), 433–439. https://doi.org/10.1053/comp.2001.26275
   PubMed Web of Science ®Google Scholar
• Kaye, A. D., Jones, M. R., Kaye, A. M., Ripoll, J. G., Galan, V., Beakley, B. D., Calixto, F., Bolden, J. L., Urman, R. D., & Manchikanti, L. (2017). Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1. Pain Physician, 20(2S), S93. https://doi.org/10.36076/ppj.2017.s109
   PubMed Web of Science ®Google Scholar
• Leipzig, R. M., Cumming, R. G., & Tinetti, M. E. (1999). Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs. Journal of the American Geriatrics Society, 47(1), 30–39. https://doi.org/10.1111/j.1532-5415.1999.tb01898.x
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. (2011). Prescription drug abuse. https://nida.nih.gov/sites/default/files/rxreportfinalprint.pdf
   Google Scholar
• Odani, S., Lin, L. C., Nelson, J. R., & Agaku, I. T. (2020). Misuse of prescription pain relievers, stimulants, tranquilizers, and sedatives among U.S. Older adults aged ≥50 years. American Journal of Preventive Medicine, 59(6), 860–872. https://doi.org/10.1016/j.amepre.2020.04.028
   PubMed Web of Science ®Google Scholar
• Otten, J. J., Dodson, E. A., Fleischhacker, S., Siddiqi, S., & Quinn, E. L. (2019). Getting research to the policy table: A qualitative study with public health researchers on engaging with policy makers. Preventing Chronic Disease, 12(4), 1–8. https://doi.org/10.5888/PCD12.140546
   Google Scholar
• Qato, D. M., Alexander, G. C., Conti, R. M., Johnson, M., Schumm, P., & Lindau, S. T. (2008). Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA – Journal of the American Medical Association, 300(24), 2867–2878. https://doi.org/10.1001/jama.2008.892
   PubMed Web of Science ®Google Scholar
• Satre, D. D., Hirschtritt, M. E., Silverberg, M. J., & Sterling, S. A. (2020). Addressing problems with alcohol and other substances among older adults during the COVID-19 pandemic. The American Journal of Geriatric Psychiatry, 28(7), 780–783. https://doi.org/10.1016/j.jagp.2020.04.012
   PubMed Web of Science ®Google Scholar
• Schepis, T. S., Klare, D. L., Ford, J. A., & McCabe, S. E. (2020a). Prescription drug misuse: Taking a lifespan perspective. Substance Abuse: Research & Treatment, 14, 38–42. https://doi.org/10.1177/1178221820909352
   Web of Science ®Google Scholar
• Schepis, T. S., Klare, D. L., Ford, J. A., & McCabe, S. E. (2020b). Prescription drug misuse: Taking a lifespan perspective. Substance Abuse: Research & Treatment, 14, 1–28. https://doi.org/10.1177/1178221820909352
   Web of Science ®Google Scholar
• Schepis, T. S., Simoni-Wastila, L., Mccabe, S. E., & Schepis, S. (2018). Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults. International Journal of Geriatric Psychiatry, 34(1), 122–129. https://doi.org/10.1002/gps.4999
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila, L., & Yang, H. K. (2006). Psychoactive drug abuse in older adults. The American Journal of Geriatric Pharmacotherapy, 4(4), 380–394. https://doi.org/10.1016/j.amjopharm.2006.10.002
   PubMedGoogle Scholar
• Siricharoen, W., & Siricharoen, N. (2015, May). How infographic should be evaluated? 558–564. https://doi.org/10.15849/icit.2015.0100
   Google Scholar
• Siricharoen, W., & Siricharoen, N. (2018). Infographic utility in accelerating better health communication. Mobile Networks & Applications, 23(1), 57–67. https://doi.org/10.1007/s11036-017-0900-3
   Web of Science ®Google Scholar
• Statistics Canada. (2020). Population estimates on July 1st, by age and sex: Table: 17-10-0005-01.
   Google Scholar
• Statistics Canada. (2021). Prescription medication use among Canadian adults, 2016 to 2019. https://www150.statcan.gc.ca/n1/daily-quotidien/210628/dq210628e-eng.htm
   Google Scholar
• Statistics Canada. (2022). Population estimates on July 1st, by age and sex. https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1710000501
   Google Scholar
• United Nations. (2019). World population ageing 2019.
   Google Scholar
• van Dam, C. S., Labuschagne, H. A., van Keulen, K., Kramers, C., Kleipool, E. E., Hoogendijk, E. O., Knol, W., Nanayakkara, P. W. B., Muller, M., Trappenburg, M. C., & Peters, M. J. L. (2022). Polypharmacy, comorbidity and frailty: A complex interplay in older patients at the emergency department. European Geriatric Medicine, 13(4), 849–857. https://doi.org/10.1007/s41999-022-00664-y
   PubMed Web of Science ®Google Scholar
• Villalobos-Gallegos, L., Pérez-López, A., Mendoza-Hassey, R., Graue-Moreno, J., & Marín-Navarrete, R. (2015). Psychometric and diagnostic properties of the Drug Abuse Screening Test (DAST): Comparing the DAST-20 vs. The DAST-10. Salud Mental, 38(2), 89–94. https://doi.org/10.17711/sm.0185-3325.2015.012
   Web of Science ®Google Scholar
• World Health Organization. (2022). Ageing and health. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:$~$:text=Common
   Google Scholar